Partnerships


Building better diagnostics

At Medix Biotechnologies, we are at the forefront of innovation in the realm of infectious disease detection. Our primary focus lies in the development, manufacturing, and distribution of pathogen detection kits that are custom-tailored for diseases such as Urinary Tract Infections (UTIs) and Sexually Transmitted Infections (STIs).

We actively engage with diagnostic laboratories on a global scale to advance the field of diagnostics. By working closely with industry stakeholders and research experts, we harness our collective expertise to address complex challenges and achieve breakthrough solutions.

Medix Biotechnologies’ partnership ecosystem not only fuels our drive for innovation but also amplifies the impact of our solutions on healthcare worldwide. These collaborations allow us to work together with our partners to revolutionize diagnostic capabilities and build a healthier future for individuals and communities around the globe.

Join us in creating faster and more accurate diagnostics.

Medix partnership programs

CLIA laboratory partnership

We partner with Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in the U.S. to improve testing processes and quality, to ensure reimbursements, and to create new products for higher efficiencies and profitability.

Quality assurance partnership

We invite laboratories and companies to collaborate with Medix on research projects relating to diagnostics. This partnership involves sharing expertise, resources, and data to advance the understanding of detection methods, develop new technologies, or evaluate the performance of existing products.

Technology licensing

We are providing a non-exclusive license of detection technologies or assays to select biotech OEMs and ODMs. This license may include rights to use, develop, and commercialize the licensed technologies within assigned territories and countries.

Distribution partnership

Select companies can become authorized distributors of Medix’s detection kits. These partners will handle distribution, marketing, and sales of the kits to diagnostic laboratories and point-of-care facilities.

Research collaboration

We invite laboratories and companies to collaborate with Medix on research projects relating to diagnostics. This partnership involves sharing expertise, resources, and data to advance the understanding of detection methods, develop new technologies, or evaluate the performance of existing products.

Co-development

We welcome laboratories and companies to collaborate with us in developing new detection technologies or assays. This partnership involves combining Medix expertise in product development and commercialization with laboratories’ clinical and research expertise. Both parties contribute to the design, validation, and optimization of a project’s detection solutions.